AAAAAA

   
Results: 1-8 |
Results: 8
Loss of bone mass and vitamin D deficiency after hematopoietic stem cell transplantation: standard prophylactic measures fail to prevent osteoporosis
Authors: Massenkeil, G Fiene, C Rosen, O Michael, R Reisinger, W Arnold, R
Citation: G. Massenkeil et al., Loss of bone mass and vitamin D deficiency after hematopoietic stem cell transplantation: standard prophylactic measures fail to prevent osteoporosis, LEUKEMIA, 15(11), 2001, pp. 1701-1705
Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathy
Authors: Rosen, O Massenkeil, G Hiepe, F Pest, S Hauptmann, S Radtke, H Burmester, G Thiel, A Radbruch, A Heymer, B Arnold, R
Citation: O. Rosen et al., Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathy, BONE MAR TR, 27(6), 2001, pp. 657-658
Relapse of systemic lupus erythematosus
Authors: Rosen, O Hiepe, F Massenkeil, G Thiel, A Arnold, R
Citation: O. Rosen et al., Relapse of systemic lupus erythematosus, LANCET, 357(9258), 2001, pp. 807-808
Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells
Authors: Rosen, O Thiel, A Massenkeil, G Hiepe, F Haupl, T Radtke, H Burmester, GR Gromnica-Ihle, E Radbruch, A Arnold, R
Citation: O. Rosen et al., Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells, ARTHRITIS R, 2(4), 2000, pp. 327-336
Immediate toxicity during fractionated total body irradiation as conditioning for bone marrow transplantation
Authors: Buchali, A Feyer, P Groll, J Massenkeil, G Arnold, R Budach, V
Citation: A. Buchali et al., Immediate toxicity during fractionated total body irradiation as conditioning for bone marrow transplantation, RADIOTH ONC, 54(2), 2000, pp. 157-162
Subacute encephalopathy after combination chemotherapy including moderate-dose methotrexate in a patient with gastric cancer
Authors: Genvresse, I Dietzmann, A Massenkeil, G Spath-Schwalbe, E Possinger, K
Citation: I. Genvresse et al., Subacute encephalopathy after combination chemotherapy including moderate-dose methotrexate in a patient with gastric cancer, ANTI-CANC D, 10(3), 1999, pp. 293-294
Temporary tracheobronchial stenting in malignant lymphoma
Authors: Schmidt, B Massenkeil, G John, M Arnold, R Witt, C
Citation: B. Schmidt et al., Temporary tracheobronchial stenting in malignant lymphoma, ANN THORAC, 67(5), 1999, pp. 1448-1450
Transient tetraparesis after intrathecal and high-dose systemic methotrexate
Authors: Massenkeil, G Spath-Schwalbe, E Flath, B Gottschalk, S Lehmann, R Arnold, R
Citation: G. Massenkeil et al., Transient tetraparesis after intrathecal and high-dose systemic methotrexate, ANN HEMATOL, 77(5), 1998, pp. 239-242
Risultati: 1-8 |